Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
<p><strong>Objective</strong> To estimate the incidence and HRs for bleeding for different dual antiplatelet therapies (DAPT) in a real-world population with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) in England. <p><strong>Design...
Main Authors: | Pufulete, M, Harris, J, Pouwels, KB, Reeves, BC, Lasserson, D, Loke, YK, Mumford, A, Mahadevan, K, Johnson, TW |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BMJ Publishing Group
2022
|
Registos relacionados
-
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
Por: Barney C Reeves, et al.
Publicado em: (2022-08-01) -
Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study)
Por: Pufulete, M, et al.
Publicado em: (2019) -
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
Por: Harris Jessica, et al.
Publicado em: (2023-05-01) -
Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with chronic coronary artery disease (CAD) - current state of knowledge and perspective for further research
Por: Hubert Bochenek, et al.
Publicado em: (2025-02-01) -
Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
Por: A. Mezier, et al.
Publicado em: (2023-03-01)